COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity, sources said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38onXd7
via IFTTT